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Detection and imaging of single cancer cells is critical for cancer diagnosis and understanding of 
cellular dynamics. Photoacoustic imaging (PAI) provides a potential tool for the study of cancer cell 
dynamics, but faces the challenge that most cancer cells lack sufficient endogenous contrast. Here we 
physically fabricated a type of colloidal gold nanoparticles (AuNPs), and precisely functionalized 
them with quantitative amounts of functional ligands (i.e. PEG and RGD peptides) to serve as an 
exogenous contrast agent for PAI of single cells. The functionalized AuNPs, with a fixed number of 
PEG but different RGD densities, were delivered into human prostate cancer cells. Radioactivity and 
photoacoustic analyses showed that, although cellular uptake efficiency of the AuNPs linearly 
increased along with RGD density, photoacoustic signal generation efficiency did not and only 
maximized at a moderate RGD density. The functionalization of the AuNPs were in turn optimized 
based on the experimental finding, and single cancer cells were imaged using a custom photoacoustic 
microscopy with high-resolution. The quantitatively functionalized AuNPs together with the high-
resolution PAI system provides a unique platform for the detection and imaging of single cancer cells, 
and may impact not only basic science but also clinical diagnostics on a range of cancers.  








Cancer is a group of fatal diseases that involve abnormal cell proliferation with the potential to invade 
and spread to other parts of the body.
[1]
 Early imaging and diagnosis of premalignant and malignant 
human cancers is essential for improving the survival rate of patients. Photoacoustic imaging (PAI), 
which is based on the conversion of light into sound, is an emerging, hybrid, and noninvasive 
biomedical imaging modality, and has been extensively explored for its applications in cancer 
detection and imaging.
[2-6]
 PAI has the advantages of high optical contrast and good ultrasound 
penetration, and can provide multi-dimensional tumor data, including structural, functional, 
metabolic, and molecular information.
[7]
 To date, most work has been focused on solid tumor 
detection at the macroscopic level.
[7-16]
 However, solid tumor usually evolves from a single cell.
[17]
 




 early tumors may 
be difficult to be detected, which limits PAI from early cancer detection and research of cellular 
dynamics.
[17, 18]
 From this standpoint, microscopic imaging of single or small numbers of cancer cells 
is highly desirable and of special significance.
[19, 20]
 This, however, imposes demanding requirements 
on the resolution and sensitivity of PAI because most cancer cells are very small in size (~10 μm) and 
exhibit little endogenous absorption contrast (except melanoma cells).
[21-26]
 To achieve high-
sensitivity PAI at the cellular level, exogenous contrast agent is preferably used to enhance optical 
absorption and amplify photoacoustic signal generation efficiency.
[27-29]
 
Plasmonic gold nanoparticles (AuNPs), the best characterized and most widely used nanomaterial 
to date, are ideal contrast enhancers for photoacoustic imaging due to their excellent biocompatibility, 
low cytotoxicity, and superb optical absorptions up to five orders of magnitude higher than those of 
traditional organic dyes.
[20, 29-33]
 AuNPs have already been used in PAI to image and diagnose a 
variety of cancers,
[7, 9-16]
 such as melanoma,
[9]















 and circulating tumor cells.
[14-16]
 Several parameters, such as size, 
shape, and surface chemistry, are critical for their photoacoustic applications.
[34]
 While the size and 
shape determine the optical properties, the surface chemistry controls the interactions of AuNPs with 
surrounding biological environments.
[30, 35]
 To achieve highly efficient delivery of AuNPs into cancer 
cells, active surface coating with functional ligands, such as hydrophilic polymers and targeting 





 and covalent coupling,
[38]
 have been developed to manipulate and modify AuNP 
surface chemistry. However, most methods are inadequate to achieve efficient and controllable 
functionalization of individual AuNPs, e.g. conjugating each AuNP with multiple types of ligands 
with precisely controlled amounts and distributions.
[39]
 Controllable functionalization to evaluate and 
optimize nanoparticle performances is important for many practical applications, such as multi-type 
cancer cells targeting and efficient drug delivery.
[40]
 Achieving controllable functionalization of 
AuNPs with quantitative amounts of multi-type ligands, although extremely important, is still a great 
challenge.  
To address the problems of high-sensitivity detection and high-resolution imaging of single or small 
populations of cancer cells, we physically produced a kind of colloidal AuNPs with bare surfaces 
using ultrafast laser ablation of a gold target immersed in deionized water, precisely coated them with 
quantitative amounts of two different functional ligands, i.e. thiol-terminated polyethylene glycol 
(PEG) molecules and cysteine-modified (Arginine(R)-Glycine(G)-Aspartic(D))4 (RGD) peptides, and 
selectively delivered them into human prostate cancer cells to serve as an exogenous absorption 
contrast. Through quantitative bioconjugation, we were able to study the cellular uptake efficiency of 
the functionalized AuNPs (fAuNPs) using radioactivity analysis and their photoacoustic signal 
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experimental results, we determined the optimal RGD ligand density that yields the highest 
photoacoustic signal amplitude, and imaged individual cancer cells using a custom high-resolution 
photoacoustic microscopy (PAM) system. 
 
2. Results and Discussion 
2.1 Synthesis of the fAuNPs with Quantitatively Controlled Bioconjugation and Targeted 
Delivery into Human Cancer Cells  
We first fabricated raw AuNPs using our patented technology,
[41]
 i.e. femtosecond laser ablation of a 
gold target submerged in flowing deionized water (see Materials and Methods and Figure S1 in the 
Supporting Information). This method uses tightly focused micro-joule (µJ) femtosecond laser pulses 
to produce nanoparticles, and the size and size distribution of generated nanoparticles can be precisely 
controlled by optimizing laser parameters, such as wavelength, pulse energy, duration, and repetition 
rate, etc.
[42]
 Colloidal AuNPs with an average diameter of 30 nm were produced and used in our 
experiments. Representative transmission electron microscopy (TEM) image, hydrodynamic particle 
size distribution and ultraviolet-visible (UV-Vis) absorption spectrum are presented in Figure 1A. The 
generated nanoparticles have a narrow size distribution and have an absorption peak at 520 nm due to 
localized surface plasmon resonance (LSPR).
[43]
 The spectral feature below 450 nm reflects gold 
intraband transitions since the nanoparticles were generated in deionized water. Since no other 
chemical components, such as chemical precursors, reducing agents, and stabilizing ligands, are 
involved in the fabrication process, the colloidal AuNPs produced using the laser ablation method are 
naturally negatively charged and surfactant-free compared with chemically synthesized 
nanoparticles.
[35]
 This unique feature allows versatile and controllable surface manipulation and 




This article is protected by copyright. All rights reserved. 
6 
 
Following the methodology developed in our previous work,
[35]
 the raw colloidal AuNPs were 
quantitatively functionalized with two different types of ligands, i.e. PEG molecules and RGD 
peptides for effective and selective targeting of cancer cells (see the first two Steps in Figure 1B and 
Materials and Methods). The functionalization was performed in a sequential manner by first mixing 
the colloidal AuNPs with PEG and then RGD peptides, both of which are terminated with thiol groups 
(SH). The quantification was achieved by precisely controlling the molar ratio of the ligands to the 
colloidal AuNPs, i.e. PEG/AuNPs and RGD/AuNPs. PEG were grafted onto the nanoparticles 
because they can improve their stability and biocompatibility, and simultaneously minimize 
nonspecific interactions with biological tissues. RGD peptides were coated on the nanoparticles 
because they can specifically bind with complementary proteins (known as receptors) on plasma 
membrane of cancer cells to improve cellular recognition and uptake, which involves a complex 
succession of biomechanical and biochemical events: docking, membrane wrapping, pinching off, 
intracellular trafficking, etc (Figure 1C). The binding of PEG molecules and RGD peptides to the 
nanoparticles is possible due to strong anchoring of the thiol-gold bonds, which covalently attach the 
chains of the ligands to the surfaces of the nanoparticles. The binding as well as quantitatively 
controlled bioconjugation were experimentally confirmed by dynamic light scattering (DLS) 
measurements (Figure S2-S4 in the Supporting Information). The two types of grafted functional 
ligands allow the AuNPs to be stably present in cellular microenvironments, and be selectively 
internalized into cancer cells via receptor-mediated endocytosis (Figure 1D). The targeted delivery 
and presence of the fAuNPs in human cancer cells was experimentally validated using TEM imaging 








Figure 1.  Physically-generated colloidal AuNPs, functionalization and cellular uptake. (A) TEM 
image, size distribution and UV-Vis absorption spectrum of the nanoparticles. (B) Sequential 








I radionuclide (for radioactivity analysis only). (C) A schematic showing cellular uptake of the 
AuNPs via receptor-mediated endocytosis. (D) Top view (left) and section view (right) of a cancer 
cell with internalized AuNPs.  
 
2.2 Radioactivity Analysis of Cellular Uptake Efficiency of the fAuNPs at Different RGD 
Densities 
Quantitative functionalization of the nanoparticles provides us a unique tool to precisely control and 
optimize the functionality of AuNPs for future clinical applications. For detection and imaging of 
single or small numbers of cancer cells, the cancer-targeting RGD ligand plays a critical role because 
its density has a direct impact on the cellular uptake efficiency and the average number of AuNPs 
internalized into per cell. This in turn is very important for preclinical testing of nanoparticles to 
evaluate dose-efficacy relationships and optimize biophysical and biochemical parameters.
[44, 45]
 A 
series of fAuNP solutions with a fixed PEG density (PEG/AuNPs = 450) but varying RGD densities 
(RGD/AuNPs from 200 to 1600) were prepared in the experiment. We then studied the dependence of 
cellular uptake efficiency of the fAuNPs on the surface RGD density using radioactivity analysis.
[46, 47]
 
By employing a gamma counter, the technique enable us to quantitatively measure gamma radiation 
from radionuclides immobilized on the AuNPs (Figure 2A and Materials and Methods). 
Due to the need of radionuclides in radioactivity analysis, the synthesized fAuNPs at different RGD 
densities were further radiolabeled with 
125
I radioisotope by simply mixing them with 
125
I sodium 
iodide solutions (see Step 3 in Figure 1B and Materials and Methods). This radiolabeling procedure 
has been proven to be efficient and stable as a result of the high affinity and strong binding of iodide 
ions with the surface of AuNPs.
[27]
 In the experiment, the 
125
I-labelled fAuNPs were delivered into 
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treated cancer cells were finally separated from culture media and washed with fresh phosphate 
buffered saline (PBS) for radioactivity analysis. All the three parts, i.e. cells, culture media, and PBS, 
contained 
125
I radionuclides. Radioactivity of each part was measured and recorded using a gamma 
counter. The percentage of radioactivity remaining in the cells was calculated to reflect the cellular 
uptake efficiency at different RGD densities (see Materials and Methods). 
The measured cellular uptake efficiency at different RGD densities are shown in Figure 2B (see 
Table S1 in the Supporting Information for raw data). Two conclusions can be drawn from the 
experimental results. First, cellular uptake of the fAuNPs is a specific targeting process, during which 
the RGD peptides play a decisive role. Without the RGD ligands, only a very limited number of 
nanoparticles could enter the cells (see the control data at RGD 0 in Figure 2B). Second, cellular 
uptake efficiency of the fAuNPs has a strong linear correlation with the surface RGD density within 
the range of 200 to 1600. This suggests that, in practical applications, we can regulate the amount of 
AuNPs delivered into each cancer cell by tuning the surface RGD density. Moreover, the results also 
indirectly support our quantitatively controlled bioconjugation claim in the previous Section, because 
cellular uptake efficiency markedly differs at different RGD densities. The radioactivity analysis 
provides us important information to quantitatively understand cellular uptake efficiency of AuNPs at 








Figure 2.  Evaluation of cellular uptake efficiency of the 
125
I-labelled AuNPs at different surface 
RGD densities using radioactivity analysis. (A) Schematic diagram showing how the gamma counter 
counts gamma radiations. (B) Experimental results showing cellular uptake efficiency of AuNPs at 
different surface RGD densities. 
 
 
2.3 Photoacoustic Analysis of Acoustic Signal Generation Efficiency of the fAuNPs at Different 
RGD Densities 
The radioactivity analysis results show cellular uptake of AuNPs increases linearly with the surface 
RGD density between 200 and 1600. Since the functionalized nanoparticles are designed for PAI, we 
further investigated the dependence of photoacoustic signal generation efficiency of intracellular 
AuNPs on the surface RGD density using our custom laser-scanning PAM (see Figure 3A and 3B, 
and Materials and Methods). The PAM system employs a 532-nm nanosecond laser as the 
illumination source to excite the samples, a two-dimensional (2D, x and y) galvanometer as the 
scanning mechanism to control the angle of the deflected beam, an achromatic lens as the objective to 
focus the laser beam, and a hydrophone as the transducer to receive excited photoacoustic waves. The 
PAM has a calibrated lateral resolution of 1.6 μm, which is sufficient for identifying single cells, such 
as cancer cells and red blood cells (RBCs, average diameter 7.2 μm,
[48]
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Information). The photoacoustic signal p generated from intracellular AuNPs at different RGD 
densities ρRGD can be written as 
 
a RGD( )p F     (1) 
where Γ is the Grüneisen parameter (constant for a particular sample), F is the laser fluence (fixed 
throughout the experiment), and μa is the optical absorption coefficient at 532 nm. The photoacoustic 
signal p is linearly proportional to the absorption coefficient μa, which is a function of the surface 
RGD density ρRGD.  
In the experiment, fAuNP solutions with different surface RGD densities were delivered into 
different groups of DU145 cells, which were cultured in Petri dishes and had a near 100% confluence 
(see Materials and Methods). Each group was randomly imaged using the PAM at five different 
regions (n = 5), each with a field of view of 1 mm × 1 mm under the same conditions. All 
photoacoustic signals within each image were summed up and the average of the five tests was used 
to represent the corresponding photoacoustic signal generation efficiency at a particular RGD density. 
The normalized results with respect to the value at RGD 200 are shown in Figure 3C. It shows that the 
photoacoustic signal generation efficiency of intracellular nanoparticles would first rise with the 
increase of RGD density, and then decline after reaching the maximum at RGD 1000. The result is 
different from that of the radioactivity analysis, but they are not necessarily contradictory because 
they reflect two different processes. Specifically, radioactivity analysis represents intracellular uptake 
efficiency of nanoparticles at different RGD densities and is essentially a biological process, while 
photoacoustic analysis indicates signal generation efficiency of intracellular nanoparticles and is 
essentially a physical process. A higher amount of cellular uptake of the nanoparticles does not 
necessarily lead to greater photoacoustic signals when aggregation happens to the internalized 
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Information). The optical absorption μa of the AuNPs depends on the LSPR, or the resonant 
oscillation of conduction electrons when stimulated by light. When the nanoparticles aggregate, the 
conduction electrons near each particle surface will be delocalized and shared amongst neighboring 
particles, which shifts the LSPR to lower energies and absorption peak to longer wavelength. The red 
shift leads to a drop in optical absorption μa at 532 nm, and, therefore, lower photoacoustic signals 
[Equation (1)]. This finding is of great importance for the optimal design of plasmonic nanoparticles 
for absorption-based biomedical applications, such as photothermal therapy and PAI. Figure 3D 
shows representative PAM images of intracellular AuNPs at different RGD densities, which reveals 








Figure 3.  Evaluation of photoacoustic signal generation efficiency of intracellular AuNPs at different 
surface RGD densities using photoacoustic analysis. (A) and (B) Schematic representation of the 
laser-scanning PAM, and enlarged view of the sample part in the red dashed box. (C) Normalized 
cumulative signal intensities of 2D photoacoustic images at different RGD densities (each data point 
with five independent measurements). The results show photoacoustic signal generation efficiency 
first rises with the increase of RGD density, and then declines after reaching the maximum at RGD 
1000. (D) Typical PAM images of intracellular AuNPs at different RGD densities. Data are presented 
as means ± SEM (standard deviation of the mean). Scale bar: 100 μm. 
 
2.4 Photoacoustic Imaging of Live Human Cancer Cells Enhanced by the fAuNPs with Optimal 
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The radioactivity analysis of cellular uptake efficiency and photoacoustic analysis of signal generation 
efficiency provides a very important foundation on optimizing the performance of the nanoparticles. 
For PAI of single or small numbers of cancer cells, we prefer maximizing the photoacoustic signal 
generation efficiency of intracellular nanoparticles to achieve high-sensitivity imaging. Using the 
experimentally-obtained optimal RGD density 1000, we carried out one more experiment to 
demonstrate high-sensitivity detection and high-resolution imaging of small numbers of cancer cells 
using the custom PAM. In this experiment, the fAuNPs with a RGD density 1000 at a concentration 
of 200 pM was delivered into DU145 cancer cells (see Materials and Methods). Treated cells with an 
about 50% confluence were used for imaging.  
The presence of the live cancer cells in the dish was first confirmed by bright-field and fluorescence 
imaging using the same optical microscope (see Materials and Methods for cell staining and 
fluorescence imaging). The co-registered bright-field and fluorescence images, presented in Figure 4A 
and 4B, show typical morphology and distribution of the DU145 cells. The cell samples were then 
transferred to the custom PAM system for imaging. No noticeable photoacoustic signals were 
observed in control cells not treated with the fAuNPs, as shown in Figure 4C. In contrast, in cells 
incubated with the fAuNPs, strong photoacoustic signals were produced and captured by the 
hydrophone. High resolution 2D photoacoustic images were delineated by scanning the galvanometer. 
Three representative PAM images and their enlarged views, showing cell distribution and 
morphology, are presented in Figure 4D - 4F. Single live DU145 cells (~20 μm in diameter) are 
clearly visible and easily discernible in the images, as marked by the dashed circles. The quantified 
signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of all images are greater than 17.0 dB 
(Note S1 in the Supporting Information), which indicates excellent image quality. Although the PAM 




This article is protected by copyright. All rights reserved. 
15 
 
look similar to those in the fluorescence image, which indirectly supports the validity of the 
photoacoustic results.  
 
Figure 4.  Detection and imaging of single human prostate cancer cells. (A) and (B) Bright-field and 
co-registered fluorescence microscopy images. (C) Control image showing no noticeable 
photoacoustic signals were observed for cells not treated with the fAuNPs. (D) - (F) Three 
representative PAM images and enlarged views. Single cancer cells in dashed circles are visible and 
discernable in the PAM images. Scale bar: 100 μm (25 μm in the close-up views). 
 
3. Conclusion 
We demonstrated high-sensitivity and high-resolution photoacoustic imaging (PAI) of single and 
small populations of live human cancer cells using quantitatively functionalized gold nanoparticles 
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with two different types of functional ligands, i.e. PEG molecules and RGD peptides, in precisely 
controlled amounts. The colloidal AuNPs were physically fabricated by ultrafast laser ablation of a 
bulk gold target in flowing deionized water, and have the advantages of being naturally negatively 
charged and surfactant-free. This unique feature allows the nanoparticles to be versatilely and 
controllably engineered with different types and precise amounts of functional ligands, and serves as 
the basis of the quantitative bioconjugation.  
The fAuNPs with different surface RGD densities were selectively delivered into human prostate 
cancer cells through receptor-mediated endocytosis. Radioactivity analysis shows that cellular uptake 
efficiency, or the number of the nanoparticles internalized into each cell, rises linearly when surface 
RGD density increases from 200 to 1600. Photoacoustic analysis reveals that photoacoustic signal 
generation efficiency first rises with the increase of RGD density, but then declines after reaching the 
maximum at RGD 1000. The decrease in photoacoustic signal generation efficiency reflects 
intracellular nanoparticle aggregation and the resulting red shift in optical absorption. This 
experimental finding helps to determine the optimal surface RGD density for achieving high-
sensitivity microscopic PAI of live human cancer cells. The platform integrating the quantitatively 
bioconjugated AuNPs with high-resolution and high-sensitivity PAI may shed new light on cellular 
imaging, molecular imaging, clinical diagnostics, and optimized cancer therapy. 
 
4. Experimental Section 
Sample Preparation: All chemicals were used as received without further purification. Thiol-
terminated PEG (PEG-SH) with a molar mass of 5000 g mol
-1
 was purchased from Creative 
PEGWorks (Chapel Hill, NC, catalog # PLS-604). Cysteine-modified (RGD)
4
 peptides (molar mass: 
1845.98 g mol
-1
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synthesized by RS synthesis LLC (Louisville, KY). PEG and RGD peptides were in powder form and 
dissolved in deionized (DI) water having an electric conductivity less than 0.7 μS cm
-1
. All solutions 
were freshly made as needed and used within twelve hours. 
Physical Production and Characterization of the Colloidal AuNPs: Colloidal AuNPs with bare 
surfaces were physically fabricated using our patented technology,
[41, 42]
 i.e. femtosecond laser 
ablation of a bulk gold target (16 mm long, 8 mm wide, 0.5 mm thick, and 99.99% purity, Alfa Aesar, 
Ward Hill, MA) in flowing deionized water (Figure S1 in the Supporting Information). The 
Ytterbium-doped femtosecond fiber laser (FCPA μJewel
TM
 D-1000, IMRA America, Ann Arbor, MI) 
operating at 1.045 μm delivered pulsed laser at a repetition rate of 100 kHz with 10 μJ pulse energy 
and 700 fs pulse duration. The emitted laser beam was first focused by an objective lens, and then 
reflected by a scanning mirror to the surface of the bulk gold target, which was submerged in flowing 
deionized water (18 MΩ·cm). The size of the laser spot on the gold target was estimated to be 50 μm, 
and its position was precisely controlled by the scanning mirror. During the ablation process, a 
translation stage was employed to produce relative movements between the laser beam and the gold 
sample.
[41, 42]
 The generated nanocolloids were stably suspended in water and did not require any 
dispersants, surfactants or stabilizers to maintain their stability. This unique advantage allows 
production of colloidal AuNPs with bare surfaces, which facilitates subsequent surface modification 
process.  
The produced colloidal AuNPs were characterized by an array of analytic instruments and 
techniques, including transmission electron microscopy (TEM), dynamic light scattering (DLS), and 
ultraviolet-visible (UV-Vis) spectroscopy. Micrographs of the colloidal AuNPs were recorded using a 
TEM (JEOL 2010F, Japan) at an accelerating voltage of 100 kV. Nanoparticle hydrodynamic 
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(Malvern Instrument, Westborough, MA). UV-Vis absorption spectra were recorded by a 
spectrophotometer (UV-3600, Shimadzu Corp., Japan). 
Quantitatively Controlled Bioconjugation of the Colloidal AuNPs: A sequential conjugation 
procedure was followed to graft quantitative PEG molecules and RGD peptides onto the surface of the 
colloidal AuNPs.
[35]
 The functionalization process comprises two steps.  
Step 1. PEGylate the colloidal AuNPs (average diameter 30 nm, optical density or OD 1) by mixing 
it with the PEG-SH solution. The molar ratio of the PEG solution to the colloidal AuNPs was tuned to 
450 (i.e. PEG/AuNPs = 450) to keep the stability of the nanoparticles, and, at the same time, avoid 
excessive surface coverage (see Figure 1B). In this way, enough surface space will be left on the 
surface of the AuNPs for subsequent RGD peptides conjugation. The mixture was allowed to stand 
for two hours at room temperature to enable sufficient conjugation of PEG with the AuNPs via thiol-
gold bonding. The PEGylated AuNP solution was centrifuged (5000 g, 10 minutes) twice with 
supernatants discarded. The final PEGylated AuNPs were collected and re-suspended in deionized 
water to an OD of 20. It is worth noticing that the conjugation of PEG molecules to the physically-
generated AuNPs is very efficient when the molar ratio between PEG molecules and AuNPs is below 
the saturation point according to our previous study.
[49]
 For this specific case, the saturation molar ratio 
is around 1000 (see Figure S2), and the experimentally adopted molar ratio 450 is well below it, 
which indicates that the conjugation of PEG molecules onto AuNPs was complete in the experiment.  
Step 2. Conjugate the PEGylated AuNPs (OD 20) with RGD peptides by mixing it with RGD 
peptides. The number of RGD peptides conjugated on the surface of the AuNPs was quantitatively 
determined by controlling the molar ratio of the RGD peptides to the AuNPs (e.g., RGD/AuNPs = 
200, 400, 600, 800, 1000, 1400, and 1600 in the experiment). The resultant solutions were allowed to 
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onto unoccupied surface space of the AuNPs. The final solutions were again centrifuged (5000 g, 10 
minutes) twice with supernatants removed. The resultant fAuNPs were collected and re-suspended in 
borate buffer (pH 8.2) to an OD of 20 as the stock solution. It should be noted that real RGD density 
(number of RGD peptides per nanoparticle) and the molar ratio mentioned here are not exactly the 
same due to possible incomplete conjugation. But below the saturation molar ratio 1600 (see Figure 
S4), more and more RGD ligands were expected to be conjugated onto the AuNPs with the increase 
of the molar ratio. Therefore, it makes sense to use the molar ratio to reflect the relative RGD density 
without affecting the final conclusion. In other words, the RGD density in this paper actually means 
the molar ratio between RGD peptides and AuNPs instead of absolute number of RGD peptides per 
nanoparticle.  
The quantitatively controlled bioconjugation of the nanoparticles with PEG molecules and RGD 
peptides were confirmed via measuring their hydrodynamic diameters and zeta potentials by using 
DLS analyses (see Figure S2-S4 in the Supporting Information).  
Cell Culture and Treatment with the fAuNPs: The human prostate carcinoma cell line (DU145, 
ATCC HTB-81), culture medium (Eagle’s minimum essential medium, EMEM, ATCC 30-2003), 
fetal bovine serum (FBS, ATCC 30-2020), and penicillin-streptomycin solution (ATCC 30-2300) 
used in the experiments were all purchased from American Type Culture Collection (ATCC, 
Manassas, VA). The DU145 cancer cells were cultured in sterile Petri dishes (9 cm in diameter) in 
EMEM supplemented with 10% FBS and 1% penicillin-streptomycin solution at 37°C in a humidified 
atmosphere containing 5% CO2. The culture media were changed every other day. 
At desired confluences, culture media were drained off from the dishes, and 2.7 mL FBS-free 
EMEM and 0.3 mL fAuNPs with a concentration of 2 nM (OD 6) were then added. The cells were 
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hours, the media and the nanoparticle solution were removed and the cells were rinsed with 3 mL 
1X PBS buffer three times to wash off excess nanoparticles. The washed cells were immersed in fresh 
media and used for subsequent imaging experiments.  
Radiolabeling fAuNPs with 
125
I and Radioactivity Analysis: Iodine-125 (
125
I) radionuclide in 10
-5
 





I]NaI solution was first diluted to an activity of 0.5 mCi mL
-1
. The diluted 
solution (0.1 mL) was mixed with the fAuNPs solution (0.5 mL) and gently agitated for 10 minutes at 
room temperature. The mixture was then centrifuged at 7000 rpm for 15 minutes to remove unbound 
iodide and washed twice using Milli‐Q® water (Merck Millipore, Billerica, MA). The 125I-labeled 
fAuNPs were then re-suspended in Milli-Q
®
 water to a concentration of 2 nM and measured using 
absorption spectroscopy at 520 nm. The radiolabeled fAuNPs were found to be stable for at least one 
week when stored in a refrigerator at 4°C. 
The radiolabeled fAuNP solution was then used to treat the DU145 cancer cells to study the cellular 
uptake efficiency of AuNPs. Specifically, 2.7 mL FBS-free EMEM and 0.3 mL 
125
I-labelled fAuNPs 
(2 nM, OD 6) were added to the cell culture dishes after draining off previous culture media. The 
immersed cells were again incubated at 37°C in a humidified atmosphere containing 5% CO2. After 
twelve hours in culture, the media containing non-binding nanoparticles were removed, and the cells 
were rinsed with 3 mL 1X PBS buffer three times to wash off excess nanoparticles. The washed cells 
were then treated with 3 mL 0.05% Trypsin‐EDTA (ethylenediaminetetraacetic acid, Thermo Fisher 
Scientific, 25200056) solution for 10 minutes to ensure detachment from the bottoms of the culture 
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Radioactivity was measured using a gamma counter (Packard Cobra II, GMI Inc., Ramsey, MN), 
which mainly consists three parts, i.e. a scintillator, a photomultiplier tube (PMT) and an optical 
window between them. It works as follows (see Figure 2A). When gamma rays radiated from the 
sample strike the scintillating crystal NaI(Tl), they will trigger the release of low-energy photons, a 
portion of which pass through the optical window and reach the photocathode of the PMT. The 
photons are then converted into photoelectrons and multiplied in the PMT. The output signal of the 
PMT is proportional to the incident gamma radiation energy, and measures the radioactivity in the 
samples. In this case, the 
125
I radionuclides exist in three different parts, i.e. cells, culture media, and 
PBS buffer used to wash the cells. The radioactivity of each part was separately measured and 
recorded using the gamma counter. A percentage, defined as the radioactivity remaining in the cells 
over the total amount of radioactivity in all three parts in each plate, was calculated to reflect the 
cellular uptake efficiency at different surface RGD densities. The percentage of radioactivity in cells 










  (2) 
where γcells, γmedia and γPBS are the radioactivity (gamma signals) in cells, culture media and PBS, 
respectively.  
TEM Imaging: Prior to TEM imaging, the treated cells were fixed in 1 mL fresh 4% 
paraformaldehyde in 1X PBS for 15 minutes and followed by three washes with 5 mL 1X PBS buffer. 
Sections were cut and stained with aqueous uranyl acetate and lead citrate, and then mounted on a 300 
mesh copper grid. The specimens were finally observed by TEM (JEOL 2010F, Japan) at an 
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Fluorescence Imaging: The stain (FilmTracer calcein red-orange biofilm stain, F10319) used in 
fluorescence imaging was purchased from Thermo Fisher Scientific. The stock staining solution was 
prepared by adding 50 μL DMSO (dimethyl sulfoxide) to 50 μg biofilm stain and mixed thoroughly 
until contents were completely dissolved. The working staining solution was prepared by diluting 10 
μL stock solution with 990 μL 1X PBS buffer.  
After draining off the culture media, 1 mL working solution was added to the dish and gently 
agitated to cover all cells. The cells were then incubated at 37°C in a humidified atmosphere 
containing 5% CO
2
 for one hour to achieve uniform labeling. Afterward, the staining medium was 
drained off and the cells were washed three times. For each wash cycle, the cells were covered with 3 
mL fresh PBS, incubated for 10 minutes and then drained. The stained cells were finally immersed in 
fresh culture media and photographed using a Leica DMIL fluorescence microscope (Leica, 
Germany) with a 10X/0.3 objective. 
PAM Imaging of Live Cancer Cells: The laser-scanning photoacoustic microscopy (PAM) was a 
custom, in-house system,
[50, 51]
 as shown in Figure 3A.  The laser source is a diode-pumped solid-state 
Nd:YAG laser (Spot-10-200-532, Elforlight Ltd, UK) with a wavelength of 532 nm and a pulse 
duration of 2 ns. The emitted laser was first collimated by a lens system, then reflected by a 2D (x, y) 
galvanometer (6230H, Cambridge Technology, Bedford, MA), and, finally, focused on the sample by 
an achromatic objective (AC254-040-A, Thorlabs, Newton, NJ) with a focal length of 40 mm and a 
numerical aperture (NA) of 0.2. The cells, grown on the bottom of Petri dish and immersed in culture 
media, absorbed laser energy and produced acoustic signals. The generated acoustic signals were 
captured by a customized hydrophone (center frequency: 35 MHz, 100% bandwidth at -6 dB), 
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card (Cobra CompuScope CS22G8, GaGe, Lockport, IL), transferred to the computer, and finally 
reconstructed using a maximum amplitude projection (MAP) algorithm for visualization. 
 
Supporting Information 
Supporting Information is available from the Wiley Online Library or from the author. 
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TOC Entry 
Photoacoustic imaging provides a unique tool for single cancer cell imaging, but faces the challenge 
of lacking sufficient endogenous contrast. Here we physically fabricated a type of colloidal gold 
nanoparticles, and quantitatively functionalized them for PAI of single cells. The work may impact 
not only basic science but also clinical diagnostics on a range of cancers.  
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